Specifically, individuals who were older, were diagnosed with nephropathy, or were classified with type 2 diabetes based upon a diagnosis of type 2 or diagnosis of type 2 and receipt of insulin had significantly lower diabetes-related prescription drug costs. The gene discussed is INS; the disease is type 2 diabetes mellitus.